Company intelligence / Profile preview

Paterna Biosciences

Salt Lake City, Utah, United Statespaternabio.com ↗

Ownership: Private
Development stage: Preclinical

Overview

Paterna Biosciences is developing a first-in-class in vitro spermatogenesis platform to generate healthy sperm from adult testicular stem cells. The company has demonstrated the ability to keep adult sperm stem cells alive and replicating longer than any other lab. Their IVS technology aims to address the significant unmet need of male infertility, which accounts for about half of all failed IVF cycles globally. The company is currently in preclinical development with plans for early-phase clinical studies starting in 2025.

Therapeutic areas: Men's Health
Modalities: In vitro spermatogenesis (IVS)Adult stem cell therapy
Industry: Biotech

Partnerships

IVIRMA/IVI-RMA Group involvement via board representation by Tony Pellicer

Beyond the preview

Go deeper on Paterna Biosciences.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Paterna Biosciences.

Explore the full profile